MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitroLisa Svartdal Normann(Oslo University Hospital), Kristine Kleivi Sahlberg(Oslo University Hospital)Scientific ReportsMay 25, 202110.1038/s41598-021-90385-2Cited by 35SaveCiteExport RISWatch citationsRelated PapersThe HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells|Molecular Oncology|2012|93